CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Chiesi USA, Inc. recalls Revcovi (elapegademase-lvlr) Injection

Read the official FDA notice

Published
9 Sept 2026
Units affected
3,002 vials
Agency
FDA
Country
United States

The hazard

Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01

Brand / company
Chiesi USA, Inc.
Codes / lots
Lot#: 1221973, Exp 3/24/2027
Distribution
MO, TN
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.